KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Finished Goods (2020 - 2023)

Historic Finished Goods for Teladoc Health (TDOC) over the last 4 years, with Q1 2023 value amounting to $26.3 million.

  • Teladoc Health's Finished Goods fell 4181.89% to $26.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $26.3 million, marking a year-over-year decrease of 4181.89%. This contributed to the annual value of $32.0 million for FY2022, which is 3493.47% down from last year.
  • As of Q1 2023, Teladoc Health's Finished Goods stood at $26.3 million, which was down 4181.89% from $32.0 million recorded in Q4 2022.
  • Teladoc Health's Finished Goods' 5-year high stood at $49.1 million during Q4 2021, with a 5-year trough of $26.3 million in Q1 2023.
  • Moreover, its 4-year median value for Finished Goods was $36.1 million (2020), whereas its average is $37.4 million.
  • Its Finished Goods has fluctuated over the past 5 years, first soared by 3853.31% in 2021, then crashed by 4181.89% in 2023.
  • Teladoc Health's Finished Goods (Quarter) stood at $35.5 million in 2020, then surged by 38.53% to $49.1 million in 2021, then plummeted by 34.93% to $32.0 million in 2022, then fell by 17.63% to $26.3 million in 2023.
  • Its Finished Goods stands at $26.3 million for Q1 2023, versus $32.0 million for Q4 2022 and $36.8 million for Q3 2022.